Detalhe da pesquisa
1.
Beta-Caryophyllene, a Cannabinoid Receptor Type 2 Selective Agonist, in Emotional and Cognitive Disorders.
Int J Mol Sci
; 25(6)2024 Mar 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38542177
2.
T1AM/TAAR1 System Reduces Inflammatory Response and ß-Amyloid Toxicity in Human Microglial HMC3 Cell Line.
Int J Mol Sci
; 24(14)2023 Jul 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37511328
3.
New Insights into Bitopic Orthosteric/Allosteric Ligands of Cannabinoid Receptor Type 2.
Int J Mol Sci
; 24(3)2023 Jan 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36768458
4.
An Efficient Aequorea victoria Green Fluorescent Protein for Stimulated Emission Depletion Super-Resolution Microscopy.
Int J Mol Sci
; 23(5)2022 Feb 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35269626
5.
Understanding Amyloid Structures and Disease: A Continuing Challenge in Health Research.
Int J Mol Sci
; 22(12)2021 Jun 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-34205606
6.
Diphenyl-Methane Based Thyromimetic Inhibitors for Transthyretin Amyloidosis.
Int J Mol Sci
; 22(7)2021 Mar 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-33800546
7.
The Role of Cannabinoids in Bone Metabolism: A New Perspective for Bone Disorders.
Int J Mol Sci
; 22(22)2021 Nov 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34830256
8.
Delivery of Thyronamines (TAMs) to the Brain: A Preliminary Study.
Molecules
; 26(6)2021 Mar 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-33799468
9.
Metabolic Reprogramming in Health and Disease.
Int J Mol Sci
; 21(8)2020 Apr 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-32316318
10.
Transthyretin Stabilization: An Emerging Strategy for the Treatment of Alzheimer's Disease?
Int J Mol Sci
; 21(22)2020 Nov 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-33212973
11.
3-Iodothyronamine and Derivatives: New Allies Against Metabolic Syndrome?
Int J Mol Sci
; 21(6)2020 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32183490
12.
Endogenous 3-Iodothyronamine (T1AM) and Synthetic Thyronamine-like Analog SG-2 Act as Novel Pleiotropic Neuroprotective Agents Through the Modulation of SIRT6.
Molecules
; 25(5)2020 Feb 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-32110992
13.
Lipolytic Effects of 3-Iodothyronamine (T1AM) and a Novel Thyronamine-Like Analog SG-2 through the AMPK Pathway.
Int J Mol Sci
; 20(16)2019 Aug 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-31434215
14.
Metabolic Reprogramming by 3-Iodothyronamine (T1AM): A New Perspective to Reverse Obesity through Co-Regulation of Sirtuin 4 and 6 Expression.
Int J Mol Sci
; 19(5)2018 May 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-29786646
15.
GC-1: A Thyromimetic With Multiple Therapeutic Applications in Liver Disease.
Gene Expr
; 17(4): 265-275, 2017 11 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-28635586
16.
Cardioprotection by ranolazine in perfused rat heart.
J Cardiovasc Pharmacol
; 64(6): 507-13, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25490416
17.
Performance in Behavioral Testing in an Animal Model of Post-Surgical Hypoparathyroidism.
J Pers Med
; 14(2)2024 Feb 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38392648
18.
A Proteomic Approach Identified TFEB as a Key Player in the Protective Action of Novel CB2R Bitopic Ligand FD22a against the Deleterious Effects Induced by ß-Amyloid in Glial Cells.
Cells
; 13(10)2024 May 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38786097
19.
The Interplay between Cannabinoid Receptors and Microglia in the Pathophysiology of Alzheimer's Disease.
J Clin Med
; 12(23)2023 Nov 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38068253
20.
Thyroxine metabolite-derived 3-iodothyronamine (T1AM) and synthetic analogs as efficient suppressors of transthyretin amyloidosis.
Comput Struct Biotechnol J
; 21: 4717-4728, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37822560